Cargando…
A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
BACKGROUND: Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has been used for many years to assess the overall activity of the fibrinolytic system. We designed a completely computerised semi-automatic 8-channel device for measurement and determination...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC113256/ https://www.ncbi.nlm.nih.gov/pubmed/11985782 http://dx.doi.org/10.1186/1472-6750-2-8 |
_version_ | 1782120233361735680 |
---|---|
author | Boudjeltia, K Zouaoui Cauchie, Ph Remacle, Cl Guillaume, M Brohée, D Hubert, JL Vanhaeverbeek, M |
author_facet | Boudjeltia, K Zouaoui Cauchie, Ph Remacle, Cl Guillaume, M Brohée, D Hubert, JL Vanhaeverbeek, M |
author_sort | Boudjeltia, K Zouaoui |
collection | PubMed |
description | BACKGROUND: Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has been used for many years to assess the overall activity of the fibrinolytic system. We designed a completely computerised semi-automatic 8-channel device for measurement and determination of fibrin clot lysis. The lysis time is evaluated by a mathematical analysis of the lysis curve and the results are expressed in minute (range: 5 to 9999). We have used this new device for Euglobulin Clot Lysis Time (ECLT) determination, which is the most common test used in laboratories to estimate plasma fibrinolytic capacity. RESULTS: The correlation between ECLT and manual method is very tight : R = 0,99; p < 10(-6). The efficiency scores of the method are <4% in intra-assay and <7% in inter-assay. It allows to achieve the tests on hyperlipaemic samples. This new device has been easily integrated in laboratory routine and allows to achieve several ECLT every day without disturbance of laboratory workflow. CONCLUSIONS: The routine use of this new device could be useful in various situations such as assessment in atherosclerosis and arteriosclerosis associated diseases, coagulation survey of liver transplantations, cardiovascular surgery or pharmacological research. It has already provided highly promising results in preliminary studies on the relation between fibrinolysis and cardiovascular risk factors. |
format | Text |
id | pubmed-113256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1132562002-05-23 A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time Boudjeltia, K Zouaoui Cauchie, Ph Remacle, Cl Guillaume, M Brohée, D Hubert, JL Vanhaeverbeek, M BMC Biotechnol Methodology Article BACKGROUND: Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has been used for many years to assess the overall activity of the fibrinolytic system. We designed a completely computerised semi-automatic 8-channel device for measurement and determination of fibrin clot lysis. The lysis time is evaluated by a mathematical analysis of the lysis curve and the results are expressed in minute (range: 5 to 9999). We have used this new device for Euglobulin Clot Lysis Time (ECLT) determination, which is the most common test used in laboratories to estimate plasma fibrinolytic capacity. RESULTS: The correlation between ECLT and manual method is very tight : R = 0,99; p < 10(-6). The efficiency scores of the method are <4% in intra-assay and <7% in inter-assay. It allows to achieve the tests on hyperlipaemic samples. This new device has been easily integrated in laboratory routine and allows to achieve several ECLT every day without disturbance of laboratory workflow. CONCLUSIONS: The routine use of this new device could be useful in various situations such as assessment in atherosclerosis and arteriosclerosis associated diseases, coagulation survey of liver transplantations, cardiovascular surgery or pharmacological research. It has already provided highly promising results in preliminary studies on the relation between fibrinolysis and cardiovascular risk factors. BioMed Central 2002-05-02 /pmc/articles/PMC113256/ /pubmed/11985782 http://dx.doi.org/10.1186/1472-6750-2-8 Text en Copyright © 2002 Boudjeltia et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Methodology Article Boudjeltia, K Zouaoui Cauchie, Ph Remacle, Cl Guillaume, M Brohée, D Hubert, JL Vanhaeverbeek, M A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time |
title | A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time |
title_full | A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time |
title_fullStr | A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time |
title_full_unstemmed | A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time |
title_short | A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time |
title_sort | new device for measurement of fibrin clot lysis: application to the euglobulin clot lysis time |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC113256/ https://www.ncbi.nlm.nih.gov/pubmed/11985782 http://dx.doi.org/10.1186/1472-6750-2-8 |
work_keys_str_mv | AT boudjeltiakzouaoui anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT cauchieph anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT remaclecl anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT guillaumem anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT broheed anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT hubertjl anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT vanhaeverbeekm anewdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT boudjeltiakzouaoui newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT cauchieph newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT remaclecl newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT guillaumem newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT broheed newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT hubertjl newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime AT vanhaeverbeekm newdeviceformeasurementoffibrinclotlysisapplicationtotheeuglobulinclotlysistime |